Montserrat D. S.
- Country
- Spain
- Department
- N/A
Research Overview
- Phase 3 Randomized Study of Perioperative Enfortumab Vedotin and Pembrolizumab Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
- Phase 3 Study of Enfortumab Vedotin and Pembrolizumab Versus Chemotherapy in Untreated Locally Advanced or Metastatic Urothelial Cancer
- Evaluation of Atezolizumab Combined with Radiotherapy in Muscle-Invasive Bladder Cancer Patients for Pathological Complete Response
Data & Insights
Has run more than one trial at 88 of 249 partner sites.
Specializations
Bladder Cancer Research
This investigator specializes in advancing treatments for muscle-invasive bladder cancer and locally advanced urothelial cancer. Their research encompasses innovative therapeutic approaches including immunotherapy concurrent with radiotherapy for bladder preservation.
- Bladder-preserving treatments
- Novel immunotherapy combinations
- Advanced urothelial cancer management
The investigator explores various treatment modalities including targeted antibody-drug conjugates and immune checkpoint inhibitors.
Prostate Cancer Studies
The investigator focuses on treating high-risk localized prostate cancer and metastatic castration-sensitive prostate cancer. Their research includes evaluation of hormone therapy combinations and targeted treatments.
- Advanced hormone therapy approaches
- Radiotherapy combinations
- Targeted molecular therapies
Their work encompasses both early-stage disease management and advanced therapeutic strategies for metastatic conditions.
Therapeutic Innovation
The investigator evaluates novel therapeutic combinations across urological cancers, including the integration of immunotherapy with conventional treatments.
- Combined modality treatments
- Personalized medicine approaches
- Long-term therapeutic outcomes
Their research extends to investigating biomarker-driven treatment strategies and innovative drug combinations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.